Skip to content

Glaukos GKOS Earnings yield

Earnings yield at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
3.6%-1.9pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.4%-1.1pp
AbbVie logo
AbbVieABBV
0.9%-0.2pp
Boston Scientific logo
Boston ScientificBSX
3.8%+2.5pp
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
1.9%-0.6pp
Exelixis logo
ExelixisEXEL
7.4%+1.1pp

Other financials

Income statement

See full
Revenue$150.6M+41.2%
Gross profit$117.2M+42.4%
Operating income-$19.9M+4.0%
Net income-$19.8M-9.0%
EPS (diluted)-$0.34-6.3%

Balance sheet

See full
Cash & equivalents$104.2M-8.8%
Total debt$105.9M-1.7%
Total equity$670.9M-12.2%
Total assets$893.3M-7.5%

Cash flow

See full
Operating cash flow-$12.5M+32.4%
CapEx$4.0M+104%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$7.68B+12.3%
Enterprise value$7.68B+12.5%
P/S13.9×-3.0×

Profitability

See full
Gross margin78.1%+2.3pp
Operating margin-36.1%+24.3pp
Net margin-34.3%+4.8pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26.4%+11.1pp
Debt / equity0.2×0.0×
Current ratio5.4×-1.1×

Where this comes from

Calculated from Glaukos’s reported figures.

Based on trailing twelve months.

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Glaukos's earnings yield?
Glaukos (GKOS) reported earnings yield of -3% in Q1 2026.
How has Glaukos's earnings yield changed year-over-year?
Glaukos's earnings yield decreased by 36.3% year-over-year, from -2.2% to -3%.
What is the long-term trend for Glaukos's earnings yield?
Over 5 years (2020 to 2025), Glaukos's earnings yield has grown at a -3.2% compound annual growth rate (CAGR), from -3.4% to -2.9%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.